Can a Patient in Intensive Care be Visited by His or Her Pet?

NCT ID: NCT06121050

Last Updated: 2025-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-03

Study Completion Date

2029-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nearly half of all intensive care patients describe symptoms of anxiety and depression after a stay in the ICU, and one in five has genuine post-traumatic stress disorder.

As a result, improving patient experience has become a priority in the ICU, and particular attention is being paid to the need to recreate a familiar environment.

Animal-mediated interventions have been developed for a number of patients over many years. These strategies are widely used with elderly patients, and patients with cognitive or psychiatric disorders, for whom the literature shows benefits on anxiety, mood or objective signs of stress.

In the vast majority of experiments carried out to date, the animals (mainly dogs) were prepared and educated for contact with patients, and their handlers trained in this activity, rather like guide dogs. Visiting a care facility with a patient's own pet is rarely described. It may run up against obstacles related to the animal's behavior or infectious risks, but it is nevertheless authorized in many establishments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intensive Care Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients who can be visited by their pets
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pet visit

Intensive care patients visited by their pets for 20 minutes

Group Type EXPERIMENTAL

Pet visit

Intervention Type OTHER

Intensive care patients visited by their pets for 20 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pet visit

Intensive care patients visited by their pets for 20 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Conscious adult patients with a pet (dog/cat).
* Patients with no or no longer hemodynamic or respiratory failure, or undergoing rehabilitation, after resolution of the acute phase or at the end of life.
* Patients affiliated to or entitled under a social security scheme.
* Patient who has given written informed consent to participate in the study.

Exclusion Criteria

* Non-stabilized acute situation (as assessed by the resuscitator).
* Mechanical or amine ventilation or extrarenal purification.
* Tracheostomy.
* Immunosuppression.
* Carriage of multi-resistant bacteria.
* Behavioral or consciousness disorders.
* Pregnancy.
* Skin wounds, extensive burns exceeding 15% of body surface area, external fixator.
* Guardianship or trusteeship.
* Workload incompatible with the visit
* Patient unable to speak French.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cindy POKRANDT

Role: PRINCIPAL_INVESTIGATOR

CHU SAINT-ETIENNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Ardèche Nord

Annonay, , France

Site Status NOT_YET_RECRUITING

Centre Hospitalier de Saint-Etienne

Saint-Etienne, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Guillaume THIERY, PhD

Role: CONTACT

0477127862 ext. 33

Cindy POKRANDT

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Vincent CADIERGUE, MD

Role: primary

Nathalie LESAINE

Role: backup

gaelle GUETON, CRA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01439-36

Identifier Type: OTHER

Identifier Source: secondary_id

21PH263

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Family Involvement in ICU
NCT06770751 RECRUITING
Web-based Follow-up to Former ICU Patients
NCT04317144 ACTIVE_NOT_RECRUITING NA
Frailty in Critical Care Unit's Patients
NCT06117462 NOT_YET_RECRUITING
MICU Recovery Clinic
NCT02560129 COMPLETED
Geriatrics in the Intensive Care Unit
NCT07001410 NOT_YET_RECRUITING